- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | BioNexus Gene Lab Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
| 14.11. | BioNexus Gene Lab Corp - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 14.11. | BioNexus Gene Lab stock hits 52-week low at $0.32 | 1 | Investing.com | ||
| 14.11. | BioNexus Gene Lab-Aktie erreicht 52-Wochen-Tief bei 0,32 US-Dollar | 1 | Investing.com Deutsch | ||
| 11.11. | BioNexus Gene Lab faces Nasdaq delisting over price rule | 2 | Investing.com | ||
| 11.11. | BioNexus Gene Lab droht Delisting von der Nasdaq aufgrund von Preisregel | 1 | Investing.com Deutsch | ||
| 08.11. | BioNexus Gene Lab Corp - 8-K, Current Report | - | SEC Filings | ||
| BIONEXUS GENE LAB Aktie jetzt für 0€ handeln | |||||
| 15.10. | BioNexus Gene Lab announces board resignations | 5 | Investing.com | ||
| 15.10. | BioNexus Gene Lab gibt Rücktritte aus dem Vorstand bekannt | 2 | Investing.com Deutsch | ||
| 10.10. | BioNexus Gene Lab sieht sich mit Auswirkungen mutmaßlicher Proxy-Probleme auf Abstimmungsergebnisse konfrontiert | 2 | Investing.com Deutsch | ||
| 10.10. | BioNexus Gene Lab faces vote impact from alleged proxy issues | 2 | Investing.com | ||
| 10.10. | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 25.09. | BioNexus Gene Lab Corp.: BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. | 128 | GlobeNewswire (Europe) | KUALA LUMPUR, Malaysia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- MRNA Scientific Sdn. Bhd. ("MRNA"), a subsidiary of BioNexus Gene Lab Corp. (Nasdaq: BGLC, the "Company"), and Protech Builders Sdn. Bhd.... ► Artikel lesen | |
| 25.09. | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 13.09. | BioNexus partners with Vitarray for gene detection | 1 | Investing.com | ||
| 13.09. | BioNexus geht Partnerschaft mit Vitarray für Gendetektion ein | 1 | Investing.com Deutsch | ||
| 13.09. | BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. | 1 | GlobeNewswire (USA) | ||
| 12.09. | BioNexus Gene Lab signs strategic partnership with Shenzhen Rongguang Group | 2 | Seeking Alpha | ||
| 12.09. | BioNexus Gene Lab Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 12.09. | BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| NANO-X IMAGING | 5,620 | -4,58 % | Nano-X Imaging Non-GAAP EPS of -$0.15 in-line, revenue of $3.03M misses by $0.5M | ||
| BUTTERFLY NETWORK | 3,455 | +3,91 % | BFLY-Aktie erreicht 52-Wochen-Hoch bei 2,95 US-Dollar | ||
| GOODRX | 4,320 | +0,23 % | GoodRx Holdings one of the most undervalued stocks, Leerink says | ||
| TALKSPACE | 3,140 | -0,63 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,190 | -1,00 % | CARMAT's Aeson Artificial Heart Is Gradually Becoming a Reference Solution for Bridge to Transplant in Europe | Milestone of 30 heart transplants post Aeson® support, passed Strong interest in Aeson® from the medical community: more than 100 European experts will share their experience at the first... ► Artikel lesen | |
| JOINT CORP | 11,350 | +0,35 % | JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3% | ||
| MIMEDX | 9,145 | +0,83 % | MIMEDX GROUP, INC. - 8-K, Current Report | ||
| HYPERFINE | 0,900 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 92,70 | 0,00 % | Looking Into PROCEPT BioRobotics' Recent Short Interest | ||
| BIOMERICA | 0,311 | -2,81 % | Biomerica secures patents for GI treatments in Europe | ||
| ATRICURE | 36,030 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| PROGYNY | 14,020 | +0,29 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
| PROPHASE LABS | 0,690 | +0,73 % | ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call Transcript | ||
| LIFEMD | 5,450 | +0,93 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen |
Das Unternehmen BIONEXUS GENE LAB CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,300 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIONEXUS GENE LAB CORP finden Sie auf Wallstreet Online.
